DMK Pharmaceuticals Other Liabilities

The latest other liabilities for DMK is $190K as of December 2022. That compares with $850K in the prior-year period — down 78.1% year over year. Investors often review this figure alongside DMK Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMK's other liabilities moved from $850K to $190K — a 78.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in DMK Pharmaceuticals's operating scale or balance-sheet position.

A other liabilities figure of $190K for DMK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMK's other liabilities ($190K), review year-over-year change from $850K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack DMK Pharmaceuticals's other liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.